Last reviewed · How we verify
NCT03598881
A Study to Assess the Impact of a Non-SLS Toothpaste Upon Oral Mucosal Desquamation
NA trial testing Treatment in Sloughing Skin in 30 participants. Completed in 21 November 2016.
21 November 2016
Quick facts
| Lead sponsor | Unilever R&D |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 19 September 2016 |
| Primary completion | 21 November 2016 |
| Estimated completion | 21 November 2016 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Treatment — full drug profile →
Conditions studied
- Sloughing Skin — all drugs for Sloughing Skin →
- Mucosal Inflammation — all drugs for Mucosal Inflammation →
Sponsor
Unilever R&D — full company profile →
Who can join
Adults 18 to 60, any sex, with Sloughing Skin or Mucosal Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to compare the effect on oral mucosal desquamation of a non-SLS toothpaste and an SLS-containing toothpaste..
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03598881
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Treatment
Trials testing the same drug.
- NCT07322211 — A Study to Evaluate the Clinical Performance and Safety of UNICON Silicone Hydrogel Daily Disposable Soft Contact Lenses · NA · recruiting
- NCT07339553 — Clinical Study of EZH2 Inhibitor Combined With PARP Inhibitor in the Treatment of Patients With Advanced or Recurrent Ep · Phase 2 · not yet recruiting
- NCT07239622 — Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Ce · Phase 2 · not yet recruiting
- NCT06935240 — Investigation of Effects of Electrical Stimulation in Women With Vaginal Laxity · NA · recruiting
- NCT07176234 — The LEADS Trial (Linking Exericise for Advancing Daily Stress Management) · NA · recruiting
Other Unilever R&D trials
Trials by the same sponsor.
- NCT06640244 — The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening · NA · completed
- NCT06413810 — The Effects of a Food Ingredient on Self-reported Stress · NA · completed
- NCT05013801 — A Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate Melasma · NA · completed
- NCT04155658 — Evaluation of Efficacy of Sodium Monofluorophosphate (SMPF) Toothpastes on Enamel Lesion Remineralisation · NA · completed
- NCT03953391 — The Effect of Tea Breaks on Cerebrovascular Perfusion During Desk Work · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03598881 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unilever R&D
- Last refreshed: 26 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03598881.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing